Back to results
US 9,309,301 B2Granted
Glucagon/GLP-1 receptor co-agonists
AssigneeIndiana University Research and Technology Corporation
InventorsRichard D. Dimarchi, David L. Smiley, Bin S. Yang
Life of this patent
Estimating the term…
Abstract
Provided herein are peptides and variant peptides that exhibit enhanced activity at the GLP-1 receptor, as compared to native glucagon.
Claims24
A peptide comprising
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.